Word of the Day

Commodity

Even if you don't think you do, you already know plenty about commodities. Want us to prove it? No problem.

What makes oil produced in Saudi Arabia different from oil exported from Nigeria? It's the same thing that makes the corn you ate at last summer¿s barbecue different from the corn used to produce ethanol. Stumped? Well, don't feel bad, it's a trick question. The answer? Absolutely nothing. Corn is corn no matter where it comes from -- just as wheat is wheat and natural gas is -- right! -- natural gas. (Though the quality may differ, the make-up is uniform.)

So, in less elaborate terms, corn and oil (and all other commodities) are homogenous goods that can be processed, resold and more often than not, used as an input to the production of other goods or services. These goods are traded on a commodity exchange, thus setting the price-per-barrel (or other metric unit) used to value them.

Now pay attention, here's a question that indeed does have an answer: What is the difference between a commodity and a stock? While a stock can tank and become worthless, a commodity cannot have its value be wiped to zero. One other difference: Most commodities are traded in futures, meaning traders buy and sell where they think the price of a product will be at a certain point in the future. Stocks trade based on the value of the underlying company at that point in time.

Home / Markets / Industries / Health Care

Monday, October 06, 2008

CryoCath Announces Filing and Mailing of Directors' Circular Unanimously Recommending Acceptance of Offer from Medtronic

Email this Story | Respond to Editor | Print

Comtex

MONTREAL, Oct. 6, 2008 (Canada NewsWire via COMTEX) ----

 << www.cryocath.com Toronto Stock Exchange Symbol: CYT >>

CryoCath(R) Technologies Inc. ("CryoCath" or the "Company") (TSX: CYT), today announced the filing and mailing of the Directors' Circular with respect to the previously announced offer from Medtronic, Inc. ("Medtronic") (NYSE: MDT), through a wholly owned subsidiary, to acquire all of the outstanding common shares of the Company. The Directors' Circular is being mailed together with the take-over bid circular of Medtronic.

The CryoCath board of directors has unanimously recommended that CryoCath shareholders accept the offer. The Directors' Circular provides details concerning the board of directors' recommendation that the Company's shareholders tender their common shares into the offer. The Directors' Circular has been filed in Canada on SEDAR at www.sedar.com and will also be available on CryoCath's website at www.cryocath.com.

About CryoCath

CryoCath - www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiac arrhythmias. With annual revenue of approximately $40 million Cdn, its products are routinely used in more than 500 centers around the world. The Company's flagship product, Arctic Front, is a minimally invasive cryo-balloon catheter designed specifically to treat Atrial Fibrillation, an emerging $2 billion market opportunity. Marketed in Europe and the subject of a pivotal study in the United States, Arctic Front has been used to treat approximately 3,100 patients.

This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's annual report available at www.sedar.com under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.

%SEDAR: 00015053EF

SOURCE: CryoCath Technologies Inc.

visit our website at www.cryocath.com, or contact:
   Ross Marshall, Investor Relations, Phone: (416) 815-0700 ext. 238, Fax: (416) 815-0080, E-mail: rmarshall@equicomgroup.com

Copyright (C) 2008 CNW Group. All rights reserved. **********************************************************************
   As of Thursday, 10-02-2008 23:59, the latest Comtex SmarTrend� Alert, an automated pattern recognition system, indicated a
   DOWNTREND on 09-17-2008 for MDT @ $52.47. For more information on SmarTrend, contact your market data provider or go to www.mysmartrend.com
   SmarTrend is a registered trademark of Comtex News Network, Inc. Copyright � 2004-2008 Comtex News Network, Inc. All rights
   reserved.